Slide background
Slide background
Slide background

Blood Test for Cancer

The ONCOblot® Test is a highly sensitive blood test for cancer. It confirms the presence of cancer as well as the tissue of origin through the detection of ENOX2 proteins.

Non-Invasive Option for Cancer Presence

The ONCOblot® Test is being used to confirm if cancer is actually present or not.  The ONCOblot® Test provides a non-invasive next step to existing tests such as a High PSA, Abnormal Mammogram, Suspicious PET Scan and biopsies.  The test is being used to identify cancer of unknown primary (CUP), for recurrence monitoring, post cancer treatments and for targeted high risk populations.

Cancer Confirmation Test

Cancer Testing with Confidence

The ENOX2 protein species in the blood is unique to malignant cells and absent from non-cancer cells.  These proteins can be detected in early development.  The ONCOblot® Test identifies the ENOX2 markers and the direct visualization of a marker presence significantly reduces false positives.

The American Academy of Anti-Aging Medicine Conference

Stop by and meet us at The American Academy of Anti-Aging Medicine Conference in Las Vegas, December 10-13.
Dr. Jim Morré and Dr. David Taggart will lecture on ENOX2 in the Cancer Fellowship program.

Reveals origin of malignant cells:

The ONCOblot® Test reveals the tissue of origin of the ENOX2 protein. The ONCOblot® database contains the following cancers:

• Bladder
• Breast
• Cervical
• Colorectal
• Endometrial
• Esophageal
• Gastric
• Hepatocellular
• Kidney

• Leukemia
• Non-Small cell
• Lung Small cell
• Lymphoma
• Melanoma
• Mesothelioma
• Multiple Myeloma
• Myeloma
• Ovarian

• Pancreatic
• Prostate
• Sarcoma
• Squamous Cell
• Follicular Thyroid
• Uterine
• Papillary Thyroid
• Testicular Germ Cell

International Expansion

We have providers in the following international areas:  China, Hong Kong, Taiwan, Switzerland, Poland, Ukraine, Russia, United Kingdom.

Read our press release.